Rising Prevalence of Multiple Sclerosis in Saudi Arabia, a Descriptive Study

Autor: Ali Almubarak, Mamdouh Kalakatawi, Ashraf El-Metwally, Shireen Qureshi, Ahmed Al-Jedai, N. Alzahrani, G. Al Towaijri, E. Mohamednour, Hussein Algahtani, Adel Alhazzani, H. Al Otaibi, Reem F. Bunyan, A. Almalki, I. Althubaiti, A. Karim, Y. Al Malik, Edward Cupler, Mohammed AlJumah, Hajer Almudaiheem, Saad Al-Rajeh, Samah Ishak, Sadaga Alawi, M. Al Mejally, Shahpar Nahrir, Jameelah Saeedi

Publikováno v: BMC Neurology
BMC Neurology, Vol 20, Iss 1, Pp 1-7 (2020)

Background In 2015, the first nationwide, multicenter Multiple Sclerosis (MS) registry was initiated in the Kingdom of Saudi Arabia (KSA) mainly with an objective to describe current epidemiology, disease patterns, and clinical characteristics of MS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16e9ffef97a9e5c226fadb4b10680fd1
https://doi.org/10.21203/rs.2.17183/v2

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia.

Autor: Bunyan R; Neurosciences Center, King Fahd Specialist Hospital (KFSH)-Dammam, Dammam, Saudi Arabia., Al Towaijri G; Neurology Department, King Fahd Medical City Hospital (KFMC), Riyadh, Saudi Arabia., Al Otaibi H; Neurology Department, King Fahd General Hospital-Jeddah, Jeddah, Saudi Arabia., Kareem A; Neurology Department, King Fahd General Hospital-Al-Madinah, Madinah, Saudi Arabia., Algahtani H; Neurology Department, King Abdul-Aziz Medical City, Jeddah, Saudi Arabia., Al Mejally M; Neurology Department, Hera General Hospital, Makkah, Saudi Arabia., Almubarak A; Neurology Department, Qatif Central Hospital, Qatif, Saudi Arabia., Alrajeh S; Neurology Department, Dr. Sulaiman Al Habib Hospital-Olaya Branch, Riyadh, Saudi Arabia., Cupler E; Department of Neurosciences, King Faisal Specialist Hospital & Research Center, Jeddah, Saudi Arabia., Qureshi S; Neurology Department, Johns Hopkins Aramco Healthcare Company (JHAH), Dhahran, Saudi Arabia., Alawi S; Neurology Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Kalakatawi M; Neurology Department, Al Nour Specialized Hospital, Makkah, Saudi Arabia., Al Malik Y; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Neurology Division, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia., Nahrir S; King Saud Medical City, Riyadh, Saudi Arabia., Alhazzani A; College of Medicine, King Saud University, Riyadh, Saudi Arabia., El-Metwally A; College of Public Health and Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Shami S; Itkan Health Consulting, Riyadh, Saudi Arabia., Ishak S; Itkan Health Consulting, Riyadh, Saudi Arabia., Almudaiheem H; Deputyship of Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia., Al-Jedai A; Deputyship of Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia., AlJumah M; Neurology Department, King Fahd Medical City Hospital (KFMC), Riyadh, Saudi Arabia.

Publikováno v: Multiple sclerosis international [Mult Scler Int] 2021 Nov 09; Vol. 2021, pp. 4226141. Date of Electronic Publication: 2021 Nov 09 (Print Publication: 2021).